Introduction Turoctocog alfa pegol is an extended half-life recombinant factor VIII (FVIII) replacement product designed to manage hemophilia A. By attaching a polyethylene glycol (PEG) molecule to the B domain of turoctocog alfa, its half-life is significantly extended, offering prolonged therapeutic effects. In clinical studies, turoctocog alfa p
Pancytopenia, a rare presentation of hyperthyroidism
825 Reached2 Comments
Male with RTI after Road Accident
2940 Reached3 Comments2 Likes
Cryopreservation of Cord Blood
1265 Reached3 Comments
Henoch-Schonlein Purpura Revisited
3736 Reached24 Comments8 Likes
Managing Aplastic Anemia
1516 Reached1 Comments2 Likes